Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Kloth

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
British Journal of Clinical Pharmacology|November 14, 2014
Integrated semi-physiological pharmacokinetic model for both sunitinib and its active metabolite SU12662Huixin Yu, Neeltje Steeghs, Jacqueline S L Kloth, et al.
European Journal of Cancer (Oxford, England : 1990)|October 21, 2017
Genetic polymorphisms in angiogenesis-related genes are associated with worse progression-free survival of patients with advanced gastrointestinal stromal tumours treated with imatinibMichiel C Verboom, Jacqueline S L Kloth, Jesse J Swen, et al.
Clinical Pharmacokinetics|February 4, 2015
Relationship Between Sunitinib Pharmacokinetics and Administration Time: Preclinical and Clinical EvidenceJacqueline S L Kloth, Lisette Binkhorst, Annelieke S de Wit, et al.
Clinical Pharmacology and Therapeutics|February 26, 2014
Association analysis of genetic polymorphisms in genes related to sunitinib pharmacokinetics, specifically clearance of sunitinib and SU12662M H M Diekstra, H J Klümpen, M P J K Lolkema, et al.
Clinical Pharmacokinetics|November 16, 2013
Predictive value of CYP3A and ABCB1 phenotyping probes for the pharmacokinetics of sunitinib: the ClearSun studyJacqueline S L Kloth, Heinz-Josef Klümpen, Huixin Yu, et al.
Breast Cancer Research and Treatment|June 8, 2015
Circadian variation in tamoxifen pharmacokinetics in mice and breast cancer patientsLisette Binkhorst, Jacqueline S L Kloth, Annelieke S de Wit, et al.
British Journal of Cancer|April 17, 2014
Pharmacokinetically guided sunitinib dosing: a feasibility study in patients with advanced solid tumoursN A G Lankheet, J S L Kloth, C G M Gadellaa-van Hooijdonk, et al.
The American Journal of Clinical Nutrition|February 6, 2019
Disentangling the genetics of lean massDavid Karasik, M Carola Zillikens, Yi-Hsiang Hsu, et al.
Nature Communications|July 21, 2017
Large meta-analysis of genome-wide association studies identifies five loci for lean body massM Carola Zillikens, Serkalem Demissie, Yi-Hsiang Hsu, et al.
Nature Communications|November 9, 2017
Erratum: Large meta-analysis of genome-wide association studies identifies five loci for lean body massM Carola Zillikens, Serkalem Demissie, Yi-Hsiang Hsu, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
British Journal of Clinical Pharmacology|November 14, 2014
Integrated semi-physiological pharmacokinetic model for both sunitinib and its active metabolite SU12662Huixin Yu, Neeltje Steeghs, Jacqueline S L Kloth, et al.
European Journal of Cancer (Oxford, England : 1990)|October 21, 2017
Genetic polymorphisms in angiogenesis-related genes are associated with worse progression-free survival of patients with advanced gastrointestinal stromal tumours treated with imatinibMichiel C Verboom, Jacqueline S L Kloth, Jesse J Swen, et al.
Clinical Pharmacokinetics|February 4, 2015
Relationship Between Sunitinib Pharmacokinetics and Administration Time: Preclinical and Clinical EvidenceJacqueline S L Kloth, Lisette Binkhorst, Annelieke S de Wit, et al.
Clinical Pharmacology and Therapeutics|February 26, 2014
Association analysis of genetic polymorphisms in genes related to sunitinib pharmacokinetics, specifically clearance of sunitinib and SU12662M H M Diekstra, H J Klümpen, M P J K Lolkema, et al.
Clinical Pharmacokinetics|November 16, 2013
Predictive value of CYP3A and ABCB1 phenotyping probes for the pharmacokinetics of sunitinib: the ClearSun studyJacqueline S L Kloth, Heinz-Josef Klümpen, Huixin Yu, et al.
Breast Cancer Research and Treatment|June 8, 2015
Circadian variation in tamoxifen pharmacokinetics in mice and breast cancer patientsLisette Binkhorst, Jacqueline S L Kloth, Annelieke S de Wit, et al.
British Journal of Cancer|April 17, 2014
Pharmacokinetically guided sunitinib dosing: a feasibility study in patients with advanced solid tumoursN A G Lankheet, J S L Kloth, C G M Gadellaa-van Hooijdonk, et al.
The American Journal of Clinical Nutrition|February 6, 2019
Disentangling the genetics of lean massDavid Karasik, M Carola Zillikens, Yi-Hsiang Hsu, et al.
Nature Communications|July 21, 2017
Large meta-analysis of genome-wide association studies identifies five loci for lean body massM Carola Zillikens, Serkalem Demissie, Yi-Hsiang Hsu, et al.
Nature Communications|November 9, 2017
Erratum: Large meta-analysis of genome-wide association studies identifies five loci for lean body massM Carola Zillikens, Serkalem Demissie, Yi-Hsiang Hsu, et al.
Pageof 2